🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: GSK2340274A

Found 14 matching trials

Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older

PHASE3

The purpose of this study is to characterize the safety, immunogenicity, an...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-11-09

Trial ID

NCT00979602

Treatments Being Tested

GSK2340274A GSK2340273A

Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age

PHASE2

The purpose of this study is to characterize the safety and immune response...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-10-20

Trial ID

NCT00976820

Treatments Being Tested

GSK2340274A GSK2340273A

Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old

PHASE2

This study is designed to characterize the safety and immunogenicity of pan...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-07-01

Trial ID

NCT01161160

Treatments Being Tested

GSK Biologicals' GSK2340274A (two different formulations)GSK Biologicals' - GSK2340272A

Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults

PHASE1

This study is designed to characterize the safety and immunogenicity of a' ...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-02-09

Trial ID

NCT01059617

Treatments Being Tested

GSK Biologicals' FluLaval®Placebo (saline)GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274A GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340273A

Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children

PHASE2

The objective of this study is to evaluate the immunogenicity and safety of...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-10-01

Trial ID

NCT01001169

Treatments Being Tested

GSK Biologicals' Pandemic influenza (H1N1) candidate vaccine (GSK2340274A)

Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1)

PHASE3

The primary purpose of the study is to assess the equivalence of the immune...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-10-12

Trial ID

NCT00979407

Treatments Being Tested

Influenza vaccine GSK2340272A Influenza vaccine GSK2340274A

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

PHASE2

The purpose of this study is to show that vaccination with a single dose of...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-02-01

Trial ID

NCT01035749

Treatments Being Tested

GSK Biologicals' Influenza investigational vaccine GSK2340274A GSK Biologicals' Influenza investigational vaccine GSK2340273A Placebo (saline)

Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old

PHASE1

This study will assess safety and immunogenicity of GSK Biologicals' H5N1 f...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-11-29

Trial ID

NCT01236040

Treatments Being Tested

GSK Biologicals' investigational vaccine GSK2590066A GSK Biologicals' investigational vaccine GSK2592984A GSK Biologicals' investigational vaccine GSK2340274A GSK Biologicals' investigational vaccine GSK2340273A Placebo

Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults

PHASE2

The purpose of this study is to characterize the safety and immunogenicity ...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-10-01

Trial ID

NCT00985673

Treatments Being Tested

GSK2340274A GSK2340273A Seasonal trivalent influenza vaccine (TIV)Saline placebo

Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

PHASE2

The purpose of this study is to characterize the safety and immunogenicity ...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-10-11

Trial ID

NCT00985088

Treatments Being Tested

GSK2340274A GSK2340273A Saline placebo

Previous Next